Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 1
2005 5
2006 3
2008 1
2009 7
2010 2
2011 9
2012 9
2013 27
2014 19
2015 16
2016 8
2017 16
2018 16
2019 12
2020 10
2021 22
2022 31
2023 38
2024 27
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Surveillance for Adverse Events After COVID-19 mRNA Vaccination.
Klein NP, Lewis N, Goddard K, Fireman B, Zerbo O, Hanson KE, Donahue JG, Kharbanda EO, Naleway A, Nelson JC, Xu S, Yih WK, Glanz JM, Williams JTB, Hambidge SJ, Lewin BJ, Shimabukuro TT, DeStefano F, Weintraub ES. Klein NP, et al. Among authors: naleway a. JAMA. 2021 Oct 12;326(14):1390-1399. doi: 10.1001/jama.2021.15072. JAMA. 2021. PMID: 34477808 Free PMC article.
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Payne AB, Watts JA, Mitchell PK, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Ball SW, DeSilva MB, Natarajan K, Sheffield T, Bride D, Arndorfer J, Naleway AL, Koppolu P, Fireman B, Zerbo O, Timbol J, Goddard K, Dixon BE, Fadel WF, Rogerson C, Allen KS, Rao S, Mayer D, Barron M, Reese SE, Rowley EAK, Najdowski M, Ciesla AA, Mak J, Reeves EL, Akinsete OO, McEvoy CE, Essien IJ, Tenforde MW, Fleming-Dutra KE, Link-Gelles R. Payne AB, et al. Among authors: naleway al. Lancet. 2024 Oct 19;404(10462):1547-1559. doi: 10.1016/S0140-6736(24)01738-0. Lancet. 2024. PMID: 39426837
Polymorphous light eruption.
Naleway AL. Naleway AL. Int J Dermatol. 2002 Jul;41(7):377-83. doi: 10.1046/j.1365-4362.2002.01467.x. Int J Dermatol. 2002. PMID: 12121545 Review. No abstract available.
Obstetric Complications and Birth Outcomes After Antenatal Coronavirus Disease 2019 (COVID-19) Vaccination.
Vesco KK, Denoble AE, Lipkind HS, Kharbanda EO, DeSilva MB, Daley MF, Getahun D, Zerbo O, Naleway AL, Jackson L, Williams JTB, Boyce TG, Fuller CC, Weintraub ES, Vazquez-Benitez G. Vesco KK, et al. Among authors: naleway al. Obstet Gynecol. 2024 Jun 1;143(6):794-802. doi: 10.1097/AOG.0000000000005583. Epub 2024 Apr 17. Obstet Gynecol. 2024. PMID: 38626447 Free PMC article.
Postmenopausal bleeding after COVID-19 vaccination.
Kauffman TL, Irving SA, Brooks N, Vesco KK, Slaughter M, Smith N, Tepper NK, Olson CK, Weintraub ES, Naleway AL; Vaccine Safety Datalink Menstrual Irregularities Workgroup. Kauffman TL, et al. Among authors: naleway al. Am J Obstet Gynecol. 2024 Jan;230(1):71.e1-71.e14. doi: 10.1016/j.ajog.2023.09.007. Epub 2023 Sep 17. Am J Obstet Gynecol. 2024. PMID: 37726057
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
Link-Gelles R, Rowley EAK, DeSilva MB, Dascomb K, Irving SA, Klein NP, Grannis SJ, Ong TC, Weber ZA, Fleming-Dutra KE, McEvoy CE, Akinsete O, Bride D, Sheffield T, Naleway AL, Zerbo O, Fireman B, Hansen J, Goddard K, Dixon BE, Rogerson C, Fadel WF, Duszynski T, Rao S, Barron MA, Reese SE, Ball SW, Dunne MM, Natarajan K, Okwuazi E, Shah AB, Wiegand R, Tenforde MW, Payne AB. Link-Gelles R, et al. Among authors: naleway al. MMWR Morb Mortal Wkly Rep. 2024 Mar 28;73(12):271-276. doi: 10.15585/mmwr.mm7312a5. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38547037 Free PMC article.
The Vaccine Safety Datalink: a model for monitoring immunization safety.
Baggs J, Gee J, Lewis E, Fowler G, Benson P, Lieu T, Naleway A, Klein NP, Baxter R, Belongia E, Glanz J, Hambidge SJ, Jacobsen SJ, Jackson L, Nordin J, Weintraub E. Baggs J, et al. Among authors: naleway a. Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502240 Review.
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.
Feldstein LR, Britton A, Grant L, Wiegand R, Ruffin J, Babu TM, Briggs Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Newes-Adeyi G, Odame-Bamfo L, Olsho LEW, Phillips AL, Rai RP, Saydah S, Smith N, Steinhardt L, Tyner H, Vandermeer M, Vaughan M, Yoon SK, Gaglani M, Naleway AL. Feldstein LR, et al. Among authors: naleway al. JAMA. 2024 Feb 6;331(5):408-416. doi: 10.1001/jama.2023.27022. JAMA. 2024. PMID: 38319331 Free PMC article.
273 results